Last reviewed · How we verify
NCT04047368
Comparison of Coronary Lithoplasty and Rotablation
NA trial testing Rotablation in Coronary Artery Disease in 70 participants. Completed in 28 June 2022.
28 June 2021
Quick facts
| Lead sponsor | University of Giessen |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 70 |
| Start date | 28 June 2019 |
| Primary completion | 28 June 2021 |
| Estimated completion | 28 June 2022 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Rotablation
- Coronary Lithoplasty
Conditions studied
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
- Calcified Atheroma — all drugs for Calcified Atheroma →
Sponsor
University of Giessen
Who can join
18 and older, any sex, with Coronary Artery Disease or Calcified Atheroma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study compares a new method of treating severely calcified coronary lesions, the intracoronary lithoplasty, with the current gold standard, the rotablation.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Rota-Lithotripsy-A Novel Bail-Out Strategy for Calcified Coronary Lesions in Acute Coronary Syndrome. The First-in-Man Experience.
Włodarczak A, Rola P, Barycki M, Kulczycki JJ, et al · · 2021 · cited 10× · PMID 33925916 · DOI 10.3390/jcm10091872
Verify or expand the search:
- PubMed search for NCT04047368
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Coronary Artery Disease
Currently open trials in the same condition.
- NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
- NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
- NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other University of Giessen trials
Trials by the same sponsor.
- NCT07505511 — Visualization of the Effects of Guideline-directed Medical Therapy (GDMT) on Improving Adherence and Quality of Life in · EARLY_PHASE1 · not yet recruiting
- NCT07488468 — Quality Improvement Project to Reduce Preoperative Fasting Times Before Elective Procedures · recruiting
- NCT06966739 — Multispectral Optoacustic Imaging in Patients With Myositis · completed
- NCT06381427 — Perioperative Interdisciplinary, Intersectoral Process Optimization in Heart Failure · NA · recruiting
- NCT06291714 — Non-invasive Measurement of the Hypotension Prediction Index for the Reduction of Intraoperative Hypotension · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04047368 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Giessen
- Last refreshed: 1 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04047368.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing